Important FDA Safety Alerts in GI: What you need to know

Boxed warning for Ocaliva (obeticholic acid) The U.S. Food and Drug Administration (FDA) issued a warning this week stating that the liver disease medicine Ocaliva (obeticholic acid) has been incorrectly dosed daily instead of weekly in patients ...

From the ACG Governors: Updated on Saline Shortages

The ACG Board of Governors meets regularly throughout the year to discuss important clinical and practice management issues impacting ACG members and our patients.  The ACG Governors recently met in Las Vegas during the 2018 ACG IBD School ...

2017 Public Policy and Practice Management Year in Review: what did ACG do for you?

2017 Public Policy and Practice Management Year in Review:   What did ACG do for you?   Another look at last year’s important policy highlights. December November October September August July June May April March February January December ...

2016 ACG National Affairs News Year in Review: ACG in Washington D.C. and State Houses across the Country

Year in Review: ACG in Washington D.C. and State Houses across the Country   ACG on Capitol Hill and Washington D.C.: ACG-FDA Visiting Fellowship Program: Dr. Kendall Beck’s Experience at the FDA Congress passes 21st Century Cures Act:  ...

ACG-FDA Visiting Fellowship Program: Dr. Kendall Beck’s Experience at the FDA

In October of 2016, Kendall Beck completed a one month rotation with the FDA’s Gastroenterology and Inborn Errors Products (DGIEP) division through ACG’s Visiting Fellowship Program.  Dr. Beck, a third year fellow at the University of California, ...

Recent FDA Safety Alerts Impacting GI

On Tuesday, June 7th, the FDA warned the public about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium): taking higher than recommended doses of both the non-prescription, over-the-counter (OTC) and prescription ...